Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Effectiveness of Tumor Necrosis Factor (TNF) Inhibitors and Tofacitinib, Overall, by Line of Therapy and by Combination Therapy

NCT04721821 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04721821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04721821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Effectiveness of Tumor Necrosis Factor (TNF) Inhibitors and Tofacitinib, Overall, by Line of Therapy and by Combination Therapy
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 22, 2021
Completion date
November 29, 2021
Enrollment
7,807 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis rheumatoid